NCT04619758 is a NA clinical trial of Emollient (sunflower oil) in Weight Gain, sponsored by Dr. Abdul Ahad Jamshaid.

Who is sponsoring NCT04619758?

NCT04619758 is sponsored by Dr. Abdul Ahad Jamshaid.

What drugs are being tested in NCT04619758?

Interventions in NCT04619758: Emollient (sunflower oil).

What condition does NCT04619758 study?

NCT04619758 studies Weight Gain.

Is NCT04619758 still recruiting?

NCT04619758 is currently completed. Last updated 6 November 2020.

Last reviewed 2020-11-06 · How we verify

NCT04619758

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Emollient Therapy In Preterm & Low Birth Weight Neonates: A Randomized Clinical Trial

Completed NA Last updated 6 November 2020

What this trial tests

NA trial testing Emollient (sunflower oil) in Weight Gain in 140 participants. Completed in 30 June 2018.

Timeline

1 January 2018

Primary endpoint
30 June 2018

30 June 2018

Quick facts

Lead sponsor	Dr. Abdul Ahad Jamshaid
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	140
Start date	1 January 2018
Primary completion	30 June 2018
Estimated completion	30 June 2018
Sites	1 location across Pakistan

Drugs / interventions tested

Emollient (sunflower oil)

Conditions studied

Weight Gain — all drugs for Weight Gain →

Sponsor

Dr. Abdul Ahad Jamshaid

Who can join

Adults 1 Day to 28 Days, any sex, with Weight Gain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to assess the impact of emollient therapy on gain in weight and length among preterm and low birth weight babies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Skin care interventions in infants for preventing eczema and food allergy.
Kelleher MM, Phillips R, Brown SJ, Cro S, et al · · 2022 · cited 29× · PMID 36373988 · DOI 10.1002/14651858.cd013534.pub3

Verify or expand the search:

Other recruiting trials for Weight Gain

Currently open trials in the same condition.

NCT05652478 — Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study · Phase 2 · recruiting
NCT07325500 — Incretin Microdosing for Cardiometabolic Health in People With HIV · Phase 2 · recruiting
NCT07190170 — Time Restricted Eating for WeIght LoSs MainTenance-2 · NA · recruiting
NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
NCT04252547 — Effect of Kangaroo Care on Test Weighing · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04619758 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Abdul Ahad Jamshaid
Last refreshed: 6 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04619758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing